Israeli Jews

Axcella Health Inc. Announces Appointment of Catherine A. Sohn, Pharm. D. to its Board of Directors

Retrieved on: 
Friday, August 23, 2019
Biotechnology, Pharmaceutical, Health, Israeli Jews, Endogenous Metabolic Modulators, Axcella Health

In addition, the Company announced that Christopher A. Viehbacher is stepping down after serving as a Board member since 2015.

Key Points: 
  • In addition, the Company announced that Christopher A. Viehbacher is stepping down after serving as a Board member since 2015.
  • Dr. Sohn also is Chairman of BioEclipse Therapeutics, a private clinical stage biotechnology company.
  • She previously served on the board of Neuralstem, Inc., a public biopharmaceutical company until 2017.
  • I am pleased to be joining the Board at an important time in Axcellas evolution and to be working with Axcellas experienced management team.

ZIM Announces Changes in its Board

Retrieved on: 
Wednesday, August 21, 2019
Herzliya, Interdisciplinary Center Herzliya, Israeli Jews

On August 6, 2019, Kenon has notified the Company that it appoints Mr. Yair Caspi as a director of the Company on its behalf.

Key Points: 
  • On August 6, 2019, Kenon has notified the Company that it appoints Mr. Yair Caspi as a director of the Company on its behalf.
  • The appointment of Mr. Caspi has become effective on August 21, 2019.
  • Mr. Caspi has served as a director in Israel Corporation Ltd since 2019.
  • Mr. Caspi holds an LLB in Law and a BA in business administration from the Interdisciplinary Center Herzliya and an International Executive MBA from Northwestern University & Tel Aviv University.

Relief for Fibromyalgia Linked to Floral Therapy Discovered in Study by Israel's Sheba Medical Center, Tel HaShomer

Retrieved on: 
Tuesday, August 13, 2019
Sheba Medical Center, Fibromyalgia, Health, Tel HaShomer, Ramat Gan, Israeli Jews

RAMAT GAN, Israel, August 12, 2019 /PRNewswire-PRWeb/ --Israeli medical researchers from Sheba Medical Center, Tel HaShomer, have produced a new study finding significant therapeutic benefits in the use of floristry as treatment for fibromyalgia.

Key Points: 
  • RAMAT GAN, Israel, August 12, 2019 /PRNewswire-PRWeb/ --Israeli medical researchers from Sheba Medical Center, Tel HaShomer, have produced a new study finding significant therapeutic benefits in the use of floristry as treatment for fibromyalgia.
  • Led by Prof. Howard Amital at Sheba Medical Center, the study included a total of 61 female fibromyalgia patients participating in a 12-week floral design class.
  • After completing the course, researchers conducted extensive surveying to gauge the effects and any change in symptoms associated with fibromyalgia.
  • Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East.

Anika Appoints James Loerop as Executive Vice President of Business Development and Strategic Planning

Retrieved on: 
Monday, July 8, 2019
Biotechnology, Pharmaceutical, Health, Israeli Jews

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced the appointment of James Loerop to the newly created position of Executive Vice President of Business Development and Strategic Planning.

Key Points: 
  • Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced the appointment of James Loerop to the newly created position of Executive Vice President of Business Development and Strategic Planning.
  • Mr. Loerop is a 30-year industry veteran with extensive expertise in business and corporate development within the biopharma sector.
  • As part of our continued efforts to transform Anika into a global commercial company, we are pleased to welcome Mr. Loerop to our executive leadership team to lead our business development strategy, said Joseph Darling, President and Chief Executive Officer of Anika Therapeutics.
  • I am excited to lead Anikas business development team during this critical phase in its evolution into a global commercial company, said James Loerop, Executive Vice President of Business Development and Strategic Planning at Anika Therapeutics.

Inaugural "Divas of Sheba" Women's Mission to Sheba Medical Center, Tel HaShomer in Israel

Retrieved on: 
Tuesday, June 25, 2019
Sheba Medical Center, Tel HaShomer, Sheba, Cities in Israel, Israeli Jews, Geography of religion, Places

"On the Divas of Sheba mission, we were able to rub elbows with some of the world's most visionary physicians and medical researchers," said Dr. Rebecca Bodok from Toronto.

Key Points: 
  • "On the Divas of Sheba mission, we were able to rub elbows with some of the world's most visionary physicians and medical researchers," said Dr. Rebecca Bodok from Toronto.
  • "It was an empowering experience to explore Sheba Medical Center and journey through Israel with like-minded women who care about the future of medical innovation and want to contribute to Sheba's success."
  • "This inspiring trip brought smart, curious women together to experience in person just how cutting-edge and compassionate Sheba Medical Center is," said Friends of Sheba Medical Center, Tel HaShomer Executive Director Molly Soboroff, who is based in Los Angeles.
  • Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East.

Sheba Medical Center, Tel HaShomer Director General Prof. Yitshak Kreiss to Attend the White House's Peace and Economic Summit in Bahrain

Retrieved on: 
Monday, June 24, 2019
Sheba Medical Center, Ramat Gan, Tel HaShomer, Israeli Jews, Israel

RAMAT GAN, Israel, June 24, 2019 /PRNewswire-PRWeb/ --Prof. Yitshak Kreiss, Director General of Israel's Sheba Medical Center Tel HaShomer, will attend the upcoming summit in Bahrain to discuss economic prospects for the Palestinian people as part of a first step in a potential Israeli-Palestinian peace plan.

Key Points: 
  • RAMAT GAN, Israel, June 24, 2019 /PRNewswire-PRWeb/ --Prof. Yitshak Kreiss, Director General of Israel's Sheba Medical Center Tel HaShomer, will attend the upcoming summit in Bahrain to discuss economic prospects for the Palestinian people as part of a first step in a potential Israeli-Palestinian peace plan.
  • As the largest and most comprehensive hospital in the Middle East, Sheba Medical Center treats patients from Israel, the West Bank, Gaza and the entire region indiscriminately.
  • The hospital is a hub for research and innovation, providing cutting-edge care to those across the Middle East and the globe.
  • Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East.

Video-based Tutorial Company proprep Wins International StartUp Competition at Israel Education Summit

Retrieved on: 
Thursday, June 6, 2019
Geography of Asia, Western Asia, Israeli Jews, Tel Aviv, Middle East, Israel

TEL AVIV, Israel, June 6, 2019 /PRNewswire/-- An international panel of edtech investors selected the video-based STEM tutorial company proprep as the most innovative and disruptive startup to pitch at the Israel Education Summit in Tel Aviv this week.

Key Points: 
  • TEL AVIV, Israel, June 6, 2019 /PRNewswire/-- An international panel of edtech investors selected the video-based STEM tutorial company proprep as the most innovative and disruptive startup to pitch at the Israel Education Summit in Tel Aviv this week.
  • "We are honored and excited to be the winner of IES 2019 Startup Competition," said Itay Koppel, co-founder of proprep.
  • The finalists in the 2019 Israel Education Summit Startup Competition winners are:
    2nd place -- AloTok, a social network for seniors.
  • Founded in 2016 by EdTech Israel, the Israel Education Summit is held annually the first week of June in Tel Aviv.

BIO Elects Dr. Jeremy Levin as New Board Chair

Retrieved on: 
Tuesday, June 4, 2019
Health, Biotechnology, Other Science, Science, Biotechnology, Israeli Jews, Jeremy Levin

The Biotechnology Innovation Organization (BIO) is pleased to announce Jeremy M. Levin, DPhil, MBBChir, Chief Executive Officer of Ovid Therapeutics, as the new Chair of its Board of Directors for the 2019-2020 term, elected at this years 2019 BIO International Convention.

Key Points: 
  • The Biotechnology Innovation Organization (BIO) is pleased to announce Jeremy M. Levin, DPhil, MBBChir, Chief Executive Officer of Ovid Therapeutics, as the new Chair of its Board of Directors for the 2019-2020 term, elected at this years 2019 BIO International Convention.
  • Dr. Levin brings to his new role decades of leadership in the discovery, development, and delivery of new medicines for patients.
  • At Ovid Therapeutics, Levin is leading the development of new therapies for rare neurological disorders.
  • Several Section Governing Boards also elected new officers:
    Members of the Executive Committee of BIOs Board of Directors for the 2019-2020 term are:

Israeli Prime Minister Netanyahu Shares View on Key World Jewish Issues

Retrieved on: 
Monday, June 3, 2019
Israeli Jews, Ashkenazi Jews, Politics of Israel, Government of Israel, Benjamin Netanyahu, Anti-Zionism, Criticism of the Israeli government

The prime minister addressed the issue of traditional bipartisan support for Israel, amid indications that Israel may become an issue of division between American political parties.

Key Points: 
  • The prime minister addressed the issue of traditional bipartisan support for Israel, amid indications that Israel may become an issue of division between American political parties.
  • "I don't think there's a big difference between the Democratic Party and the Republican Party as I have known it over the years on these issues," said Netanyahu.
  • On an issue of heightened concern to many American Jews, the state of Israel-Diaspora relations, the prime minister was sympathetic.
  • Turning to the issue of rising anti-Semitism, the prime minister acknowledged its "enduring resilience" after nearly 3,000 years.

AJC Completes First-Ever Concurrent Surveys of U.S., French, and Israeli Jews

Retrieved on: 
Sunday, June 2, 2019
Geography of Asia, Semitic-speaking peoples, Western Asia, Middle East, Arab–Israeli conflict, Israeli Jews, Golan Heights, Jews, Israel

AJC, the leading global Jewish advocacy organization, has polled U.S. Jews annually for decades, and last year, for the first time, also polled Israeli Jews.

Key Points: 
  • AJC, the leading global Jewish advocacy organization, has polled U.S. Jews annually for decades, and last year, for the first time, also polled Israeli Jews.
  • The addition of French Jews to the mix this year provides a uniquely trifocal view of what Jews think.
  • And, 16% of American, 27% of French, and 23% Israeli Jews consider both identity factors equally.
  • In addition, while 50% of American Jews support the Trump administration's recognition of the Golan Heights as Israeli territory, 88% of Israeli Jews do.